Dr. Berry is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St Fl 8
Boston, MA 02114Phone+1 617-724-3914
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2006 - 2009
Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 2005 - 2006
Northwestern University The Feinberg School of MedicineClass of 2005
Certifications & Licensure
MA State Medical License 2009 - 2025
American Board of Psychiatry and Neurology Neurology- American Board of Psychiatry and Neurology Neuromuscular Medicine
Clinical Trials
- A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers Start of enrollment: 2011 Nov 01
- Gilenya in Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2013 Aug 01
- Longitudinal Study of Outcomes Measures in ALS Trials Start of enrollment: 2013 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- Clinician Perspectives Highlight the Need for Early Dyadic Coping Skills for People Living With Amyotrophic Lateral Sclerosis.Christina L Rush, Chris Lyons, Jenna Gittle, Morgan Seward, Jennifer Scalia
Journal of Pain and Symptom Management. 2025-03-01 - Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.Sabrina Paganoni, Christina N Fournier, Eric A Macklin, Lori B Chibnik, Melanie Quintana
JAMA Network Open. 2025-02-03 - Effects of COVID-19 on motor neuron disease mortality in the United States: a population-based cross-sectional study.Jaime Raymond, James D Berry, Theodore Larson, D Kevin Horton, Paul Mehta
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2025-02-01
Press Mentions
Mitsubishi Tanabe Pharma America Announces Real-World Data Analysis of Disease Progression with RADICAVA® (Edaravone) in ALSJanuary 29th, 2025- Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS AssociationNovember 19th, 2024
- First Participant Enrolled in NIH-Funded Access for All in ALS ConsortiumAugust 12th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
